Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-31

Clinical Trial Update: Investigating the Effect of Vortioxetine in Adult ADHD Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating vortioxetine in adults with attention-deficit/hyperactivity disorder has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (Brintellix/Trintellix) (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-01-31